Disrupting the beauty market with technologies that deliver best in class, innovative and personalised beauty experiences.
The Investment Opportunity
Working in partnership with industry leading cosmetics brands, Trigenex is working to disrupt the beauty market with technologies that deliver best in class, innovative and personalised beauty experiences. The Company has produced three key products, with the overarching aim of disrupting the cosmetics industry by being the only technology currently on the market which produces a unique product for every customer.
The Company’s products can also be offered in conjunction with beauty brands and retailers by offering a white-label version of the Company’s product. This developed technology is able to work with the brand’s formula, whist also providing shade matching capabilities, adapting and personalising the end result for consumers.
Originally focused on providing in-store experiences in partnership with major retailers, the Company has subsequently developed an impressive online proposition which has attracted interest from a number of high profile cosmetic brands. This is operating in conjunction with the original in-store proposition, and the Company is now working with a number of high street retailers to roll out paid for trials.
Whilst continuing the fine-tune its products, the Company is now focused on accelerating commercial revenues and expanding its partnership network.
Milestones to Date
| 2018 | Deepbridge initially invested in March 2018 via the Deepbridge Innovation SEIS. |
|---|---|
| 2019 | Commenced consumer and in-store trials for ‘The Alchemist’ and ‘ShadePro’, receiving 100% satisfaction ratings. |
| 2020 | Head of Terms signed for commercial pilot of ‘The Alchemist’ device with a global cosmetics retail group. eCommerce platform launched for the latest product in the pipeline, DCYPHER. Announced as a Beauty Connect 2020 finalist. Technology rolled out with A.S. Watson Group, the world’s largest international health and beauty retailer. |
| 2021 | Funding round led by Seedrs and matched with the UK Government’s Future Fund. Won Cosmopolitan’s ‘Best Custom Foundation of the Year’ award. |
Risks and Important Information
This page is a financial promotion for the purposes of Section 21 of the Financial Services and Markets Act 2000. The content of the page has been approved by Deepbridge Capital LLP. The Company may not gain the commercial traction that is forecast, it could experience development problems and may not be able to achieve its objectives. Please note that these risks are by no means exhaustive and there may be other risks which could have a material adverse impact on the Company’s financial performance. The content should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors could lose the total value of their investment. Investments in small unquoted companies carry a high- level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Tax treatment depends on the individual circumstances of each investor and may be subject to change in future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Deepbridge does not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.